Terms: = Skin cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Prognosis
19 results:
1. The first case of Chinese phacomatosis pigmentokeratotica diagnosed by a missense hras mosaicism.
Huang L; Zhang J; Chen F; Zhang X; Cao Y; Cheng R; Deng D
J Dermatol; 2022 Sep; 49(9):921-924. PubMed ID: 35567308
[TBL] [Abstract] [Full Text] [Related]
2. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome.
Tessier-Cloutier B; Pors J; Thompson E; Ho J; Prentice L; McConechy M; Aguirre-Hernandez R; Miller R; Leung S; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Hoang LN
Mod Pathol; 2021 Feb; 34(2):508-518. PubMed ID: 32792599
[TBL] [Abstract] [Full Text] [Related]
3. Post-radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long-term follow-up and literature review.
Corradini AG; Asioli S; Morandi L; Brotto M; Righi A; Iommi M; Agostinelli C; Rucci P; Asioli S; Sapino A; Viale G; Foschini MP
Histopathology; 2020 Aug; 77(2):293-302. PubMed ID: 32043616
[TBL] [Abstract] [Full Text] [Related]
4. SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway.
Zhou S; Liang Y; Zhang X; Liao L; Yang Y; Ouyang W; Xu H
J Invest Dermatol; 2020 Feb; 140(2):395-403.e6. PubMed ID: 31401046
[TBL] [Abstract] [Full Text] [Related]
5. Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules.
Boussadia Z; Lamberti J; Mattei F; Pizzi E; Puglisi R; Zanetti C; Pasquini L; Fratini F; Fantozzi L; Felicetti F; Fecchi K; Raggi C; Sanchez M; D'Atri S; Carè A; Sargiacomo M; Parolini I
J Exp Clin Cancer Res; 2018 Oct; 37(1):245. PubMed ID: 30290833
[TBL] [Abstract] [Full Text] [Related]
6. Primary and secondary mucosal melanoma of the small intestine - a clinical, pathological, and genetic nationwide survey of Danish patients between 1980 and 2014.
Tingsgaard JK; Henriksen A; Mikkelsen LH; Behrendt N; Melchior LC; Svendsen LB; Heegaard S
APMIS; 2018 Sep; 126(9):739-745. PubMed ID: 30160023
[TBL] [Abstract] [Full Text] [Related]
7. Association of Oncogenic Mutations in Patients With Advanced Cutaneous Squamous Cell Carcinomas Treated With Cetuximab.
Picard A; Pedeutour F; Peyrade F; Saudes L; Duranton-Tanneur V; Chamorey E; Cardot-Leccia N; Sudaka A; Ettaiche M; Benchetrit M; Poissonnet G; Weinbreck N; Dadone B; Lacour JP; Passeron T; Montaudié H
JAMA Dermatol; 2017 Apr; 153(4):291-298. PubMed ID: 28259104
[TBL] [Abstract] [Full Text] [Related]
8. Identification of recurrent mutational events in anorectal melanoma.
Yang HM; Hsiao SJ; Schaeffer DF; Lai C; Remotti HE; Horst D; Mansukhani MM; Horst BA
Mod Pathol; 2017 Feb; 30(2):286-296. PubMed ID: 27739435
[TBL] [Abstract] [Full Text] [Related]
9. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract] [Full Text] [Related]
10. MEK targeting in n-ras mutated metastatic melanoma.
Thumar J; Shahbazian D; Aziz SA; Jilaveanu LB; Kluger HM
Mol Cancer; 2014 Mar; 13():45. PubMed ID: 24588908
[TBL] [Abstract] [Full Text] [Related]
11. RAF265 inhibits the growth of advanced human melanoma tumors.
Su Y; Vilgelm AE; Kelley MC; Hawkins OE; Liu Y; Boyd KL; Kantrow S; Splittgerber RC; Short SP; Sobolik T; Zaja-Milatovic S; Dahlman KB; Amiri KI; Jiang A; Lu P; Shyr Y; Stuart DD; Levy S; Sosman JA; Richmond A
Clin Cancer Res; 2012 Apr; 18(8):2184-98. PubMed ID: 22351689
[TBL] [Abstract] [Full Text] [Related]
12. p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors.
Gallagher SJ; Thompson JF; Indsto J; Scurr LL; Lett M; Gao BF; Dunleavey R; Mann GJ; Kefford RF; Rizos H
Neoplasia; 2008 Nov; 10(11):1231-9. PubMed ID: 18953432
[TBL] [Abstract] [Full Text] [Related]
13. Malignant melanoma of the anal region.
Heyn J; Placzek M; Ozimek A; Baumgaertner AK; Siebeck M; Volkenandt M
Clin Exp Dermatol; 2007 Sep; 32(5):603-7. PubMed ID: 17376215
[TBL] [Abstract] [Full Text] [Related]
14. B-RAF and n-ras mutations are preserved during short time in vitro propagation and differentially impact prognosis.
Ugurel S; Thirumaran RK; Bloethner S; Gast A; Sucker A; Mueller-Berghaus J; Rittgen W; Hemminki K; Becker JC; Kumar R; Schadendorf D
PLoS One; 2007 Feb; 2(2):e236. PubMed ID: 17311103
[TBL] [Abstract] [Full Text] [Related]
15. A novel n-ras mutation in malignant melanoma is associated with excellent prognosis.
Demunter A; Ahmadian MR; Libbrecht L; Stas M; Baens M; Scheffzek K; Degreef H; De Wolf-Peeters C; van Den Oord JJ
Cancer Res; 2001 Jun; 61(12):4916-22. PubMed ID: 11406571
[TBL] [Abstract] [Full Text] [Related]
16. Genes involved in melanoma: an overview of INK4a and other loci.
Castellano M; Parmiani G
Melanoma Res; 1999 Oct; 9(5):421-32. PubMed ID: 10596908
[TBL] [Abstract] [Full Text] [Related]
17. The chemoresistance of human malignant melanoma: an update.
Serrone L; Hersey P
Melanoma Res; 1999 Feb; 9(1):51-8. PubMed ID: 10338334
[TBL] [Abstract] [Full Text] [Related]
18. Merkel cell carcinoma of the vulva.
Gil-Moreno A; Garcia-Jiménez A; González-Bosquet J; Esteller M; Castellví-Vives J; Martínez Palones JM; Xercavins J
Gynecol Oncol; 1997 Mar; 64(3):526-32. PubMed ID: 9062165
[TBL] [Abstract] [Full Text] [Related]
19. Extensive extramedullary disease in myeloma. An uncommon variant with features of poor prognosis and dedifferentiation.
Sanal SM; Yaylaci M; Mangold KA; Pantazis CG
Cancer; 1996 Apr; 77(7):1298-302. PubMed ID: 8608506
[TBL] [Abstract] [Full Text] [Related]